

Learn about Emgality side effects, from common injection site reactions to serious warnings. Know what's normal and when to call your doctor.
Starting a new medication always comes with questions — and when it involves giving yourself a monthly injection, those questions tend to multiply. If you've been prescribed Emgality (Galcanezumab) for migraine prevention or episodic cluster headache, understanding the potential side effects can help you feel more prepared and less anxious about your treatment.
The good news: most people tolerate Emgality well, and the most common side effects are mild and temporary. But there are a few things you should watch for. Here's what the clinical data and FDA labeling actually say.
Emgality is a CGRP-blocking monoclonal antibody made by Eli Lilly. It was FDA-approved in September 2018 for migraine prevention and in June 2019 for episodic cluster headache. You inject it once a month under the skin using a prefilled pen or syringe. For a deeper look at how it works, dosing, and more, see our full guide: What Is Emgality?
Based on FDA labeling and clinical trial data, the most frequently reported side effects of Emgality include:
These side effects are generally mild and tend to improve over time as your body adjusts to the medication. Injection site reactions usually resolve within a few hours to a day.
While rare, there are some serious side effects associated with Emgality that require immediate medical attention:
Important: Emgality does not carry a boxed warning (the FDA's most serious warning level). This sets it apart from many other migraine medications.
Contact your healthcare provider right away if you experience:
If you experience signs of anaphylaxis (difficulty breathing, rapid heartbeat, severe swelling), call 911 or go to the nearest emergency room immediately.
There is limited data on Emgality use during pregnancy. Animal studies did not show harm, but there are no adequate studies in pregnant women. If you are pregnant or planning to become pregnant, talk to your doctor about whether the benefits outweigh the risks.
It's unknown whether Galcanezumab passes into breast milk. Discuss with your doctor before using Emgality while breastfeeding.
Emgality has not been studied in patients under 18 years old. It is not currently approved for pediatric use.
Clinical trials did not show significant differences in side effects for older adults compared to younger patients.
Because Emgality is a monoclonal antibody that is cleared through natural protein breakdown (catabolism) rather than by the kidneys or liver, no dose adjustment is needed for patients with kidney or liver impairment.
If you're experiencing mild side effects, these tips may help:
Most mild side effects improve after the first few months of treatment. If any side effect is significantly affecting your quality of life, talk to your doctor — they may adjust your treatment plan or explore alternative medications.
Emgality has been on the market since 2018, giving us several years of real-world safety data. Long-term extension studies have not revealed new safety concerns beyond what was observed in the original clinical trials. The most notable long-term consideration is the development of anti-drug antibodies, which occurs in a small percentage of patients but has not been shown to significantly affect the medication's efficacy or safety.
Emgality is generally well-tolerated, with injection site reactions being the most common side effect. Serious allergic reactions are rare but important to recognize. The key is knowing what's normal (mild injection site soreness, occasional constipation) versus what needs medical attention (difficulty breathing, severe swelling, persistent rash).
If you're starting Emgality and want to track your side effects over time, consider keeping a simple log of what you notice after each injection. This gives you and your doctor concrete data to work with at follow-up visits.
Ready to start Emgality? Use Medfinder to find a pharmacy with Emgality in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.